×
-0.00283667621776505 -0.00286532951289405 0.0131805157593123 0.0236389684813754 0.0559598853868195 0.0830945558739255 0.103180515759312 0.0339828080229226
Stockreport

MannKind latest biotech breakout, up 32% [Seeking Alpha]

MANNKIND (MNKD)  More Company Research Source: Seeking Alpha
Last mannkind earnings: 11/7 04:01 pm Check Earnings Report
PDF MannKind latest biotech breakout, up 32%MannKind (MNKD+32%) is up more than a 5x surge in volume. Shares have rallied over 42% since Tuesday.No particular news accounts for the action. Next Tuesday, CEO Michael Castagna will present ancorporate overview at NobelCon14.At the end of Q3 2017, the company had ~$20M in cash. Through the first three quarters, operations consumed almost $35M so the company will need additional capital to support the commercialization of Afrezza.See all stocks on the move »Now read:Could The FDA's Less Stringent Regulations Help MannKind? » [Read more]

IMPACT SNAPSHOT EVENT TIME: MNKD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS